A new study suggests that high doses of vitamin D supplements could help reduce disease activity among multiple sclerosis ...
Live Science on MSN13d
In a 1st, trial finds vitamin D supplements may slow multiple sclerosis. But questions remain.A new clinical trial has shown for the first time that taking high doses of vitamin D could stave off the progression of ...
Treatment with high-dose vitamin D reduced disease activity in people with clinically isolated syndrome in a Phase 3 trial.
ScienceAlert on MSN5d
Vitamin D Could Be an Effective Way to Slow Progress of MSResearchers from institutions across France have uncovered solid clinical evidence that supplements of vitamin D could be an ...
Roche Holdings AG (OTC:RHHBY) on Wednesday announced data from MUSETTE Phase 3 trial of a high dose of Ocrevus (ocrelizumab) ...
Tom Nolan reviews this week’s research There are so many studies published about vitamin D—about a dozen each day—it’s hard to keep up. One that stands out is a double-blind randomised controlled ...
High-dose oral cholecalciferol (vitamin D3) supplementation significantly reduced disease activity in patients with clinically isolated syndrome (CIS) suggestive of multiple sclerosis (MS ...
A significant benefit was observed with Tysabri over Rebif in delaying SPMS disability progression when therapeutic lag was ...
Cycle Pharmaceuticals Limited (Cycle) is pleased to announce that Cycle Vita is now available with BAFIERTAM, expanding its patient support services in MS, following the acquisition of Banner Life ...
Graves disease had similar presentation but a more severe clinical course when isolated than when part of autoimmune polyglandular syndrome.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback